位置:首页 > 蛋白库 > SUSD4_HUMAN
SUSD4_HUMAN
ID   SUSD4_HUMAN             Reviewed;         490 AA.
AC   Q5VX71; D3DTB9; Q6UX62; Q9BSR0; Q9NWG0;
DT   03-OCT-2006, integrated into UniProtKB/Swiss-Prot.
DT   07-DEC-2004, sequence version 1.
DT   03-AUG-2022, entry version 135.
DE   RecName: Full=Sushi domain-containing protein 4;
DE   Flags: Precursor;
GN   Name=SUSD4; ORFNames=UNQ196/PRO222;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND ALTERNATIVE SPLICING.
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Ovary;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   TISSUE SPECIFICITY, FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=23482636; DOI=10.1096/fj.12-222042;
RA   Holmquist E., Okroj M., Nodin B., Jirstrom K., Blom A.M.;
RT   "Sushi domain-containing protein 4 (SUSD4) inhibits complement by
RT   disrupting the formation of the classical C3 convertase.";
RL   FASEB J. 27:2355-2366(2013).
CC   -!- FUNCTION: Acts as complement inhibitor by disrupting the formation of
CC       the classical C3 convertase. Isoform 3 inhibits the classical
CC       complement pathway, while membrane-bound isoform 1 inhibits deposition
CC       of C3b via both the classical and alternative complement pathways.
CC       {ECO:0000269|PubMed:23482636}.
CC   -!- INTERACTION:
CC       Q5VX71-3; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-12017810, EBI-16439278;
CC       Q5VX71-3; Q9UHD9: UBQLN2; NbExp=3; IntAct=EBI-12017810, EBI-947187;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Membrane {ECO:0000305}; Single-pass
CC       type I membrane protein {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Secreted
CC       {ECO:0000305|PubMed:23482636}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=SUSD4a {ECO:0000303|PubMed:23482636};
CC         IsoId=Q5VX71-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q5VX71-2; Sequence=VSP_020840, VSP_020843;
CC       Name=3; Synonyms=SUSD4b {ECO:0000303|PubMed:23482636};
CC         IsoId=Q5VX71-3; Sequence=VSP_020841, VSP_020842;
CC       Name=4;
CC         IsoId=Q5VX71-4; Sequence=VSP_020838, VSP_020839;
CC   -!- TISSUE SPECIFICITY: Isoform 3 is the predominant isoform in all tissues
CC       except cortex, cerebellum, kidney, and breast. Isoform 1 is found
CC       primarily in the esophagus and the brain.
CC       {ECO:0000269|PubMed:23482636}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY358495; AAQ88859.1; -; mRNA.
DR   EMBL; AK000914; BAA91421.1; -; mRNA.
DR   EMBL; AL359733; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL359979; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471100; EAW93260.1; -; Genomic_DNA.
DR   EMBL; CH471100; EAW93261.1; -; Genomic_DNA.
DR   EMBL; BC004888; AAH04888.1; -; mRNA.
DR   CCDS; CCDS31034.1; -. [Q5VX71-3]
DR   CCDS; CCDS41471.1; -. [Q5VX71-1]
DR   RefSeq; NP_001032252.1; NM_001037175.2. [Q5VX71-3]
DR   RefSeq; NP_060452.3; NM_017982.3. [Q5VX71-1]
DR   RefSeq; XP_016857076.1; XM_017001587.1. [Q5VX71-1]
DR   RefSeq; XP_016857077.1; XM_017001588.1. [Q5VX71-1]
DR   AlphaFoldDB; Q5VX71; -.
DR   SMR; Q5VX71; -.
DR   BioGRID; 120379; 48.
DR   IntAct; Q5VX71; 36.
DR   MINT; Q5VX71; -.
DR   STRING; 9606.ENSP00000344219; -.
DR   GlyGen; Q5VX71; 3 sites.
DR   iPTMnet; Q5VX71; -.
DR   PhosphoSitePlus; Q5VX71; -.
DR   BioMuta; SUSD4; -.
DR   DMDM; 74747494; -.
DR   jPOST; Q5VX71; -.
DR   MassIVE; Q5VX71; -.
DR   PaxDb; Q5VX71; -.
DR   PeptideAtlas; Q5VX71; -.
DR   PRIDE; Q5VX71; -.
DR   ProteomicsDB; 65576; -. [Q5VX71-1]
DR   ProteomicsDB; 65577; -. [Q5VX71-2]
DR   Antibodypedia; 34634; 80 antibodies from 16 providers.
DR   DNASU; 55061; -.
DR   Ensembl; ENST00000343846.7; ENSP00000344219.3; ENSG00000143502.16. [Q5VX71-1]
DR   Ensembl; ENST00000344029.6; ENSP00000339926.6; ENSG00000143502.16. [Q5VX71-3]
DR   Ensembl; ENST00000366878.9; ENSP00000355843.4; ENSG00000143502.16. [Q5VX71-1]
DR   Ensembl; ENST00000681305.1; ENSP00000505262.1; ENSG00000143502.16. [Q5VX71-1]
DR   Ensembl; ENST00000681669.1; ENSP00000505495.1; ENSG00000143502.16. [Q5VX71-1]
DR   GeneID; 55061; -.
DR   KEGG; hsa:55061; -.
DR   MANE-Select; ENST00000366878.9; ENSP00000355843.4; NM_017982.4; NP_060452.3.
DR   UCSC; uc001hnx.3; human. [Q5VX71-1]
DR   CTD; 55061; -.
DR   DisGeNET; 55061; -.
DR   GeneCards; SUSD4; -.
DR   HGNC; HGNC:25470; SUSD4.
DR   HPA; ENSG00000143502; Tissue enhanced (brain, esophagus).
DR   MIM; 615827; gene.
DR   neXtProt; NX_Q5VX71; -.
DR   OpenTargets; ENSG00000143502; -.
DR   PharmGKB; PA142670855; -.
DR   VEuPathDB; HostDB:ENSG00000143502; -.
DR   eggNOG; ENOG502QU1F; Eukaryota.
DR   GeneTree; ENSGT00940000160410; -.
DR   HOGENOM; CLU_077058_0_0_1; -.
DR   InParanoid; Q5VX71; -.
DR   OMA; IIACHEG; -.
DR   OrthoDB; 560016at2759; -.
DR   PhylomeDB; Q5VX71; -.
DR   TreeFam; TF332459; -.
DR   PathwayCommons; Q5VX71; -.
DR   SignaLink; Q5VX71; -.
DR   BioGRID-ORCS; 55061; 9 hits in 1063 CRISPR screens.
DR   ChiTaRS; SUSD4; human.
DR   GenomeRNAi; 55061; -.
DR   Pharos; Q5VX71; Tbio.
DR   PRO; PR:Q5VX71; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q5VX71; protein.
DR   Bgee; ENSG00000143502; Expressed in lower esophagus mucosa and 169 other tissues.
DR   ExpressionAtlas; Q5VX71; baseline and differential.
DR   Genevisible; Q5VX71; HS.
DR   GO; GO:0005576; C:extracellular region; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0006958; P:complement activation, classical pathway; IEA:UniProtKB-KW.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0045957; P:negative regulation of complement activation, alternative pathway; IDA:UniProtKB.
DR   GO; GO:0045959; P:negative regulation of complement activation, classical pathway; IDA:UniProtKB.
DR   GO; GO:0030449; P:regulation of complement activation; IDA:UniProtKB.
DR   CDD; cd00033; CCP; 4.
DR   InterPro; IPR042985; SUSD4.
DR   InterPro; IPR035976; Sushi/SCR/CCP_sf.
DR   InterPro; IPR000436; Sushi_SCR_CCP_dom.
DR   PANTHER; PTHR47007; PTHR47007; 1.
DR   Pfam; PF00084; Sushi; 4.
DR   SMART; SM00032; CCP; 4.
DR   SUPFAM; SSF57535; SSF57535; 4.
DR   PROSITE; PS50923; SUSHI; 4.
PE   1: Evidence at protein level;
KW   Alternative splicing; Complement pathway; Disulfide bond; Glycoprotein;
KW   Immunity; Innate immunity; Membrane; Reference proteome; Repeat; Secreted;
KW   Signal; Sushi; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..41
FT                   /evidence="ECO:0000255"
FT   CHAIN           42..490
FT                   /note="Sushi domain-containing protein 4"
FT                   /id="PRO_0000251975"
FT   TOPO_DOM        42..319
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        320..340
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        341..490
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          55..119
FT                   /note="Sushi 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          120..179
FT                   /note="Sushi 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          178..239
FT                   /note="Sushi 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DOMAIN          241..304
FT                   /note="Sushi 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   REGION          1..21
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          401..490
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        422..472
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   CARBOHYD        104
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        134
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        192
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        57..99
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DISULFID        85..117
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DISULFID        122..165
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DISULFID        147..177
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DISULFID        180..224
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DISULFID        210..237
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DISULFID        243..289
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   DISULFID        274..302
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00302"
FT   VAR_SEQ         186..236
FT                   /note="SSNGYVNISELQTSFPVGTVISYRCFPGFKLDGSAYLECLQNLIWSSSPPR
FT                   -> PQHTPAQGTRTQAQGSQKPVTASQALLSCSKVCIHLPGAKRAPTLLRTTLT (in
FT                   isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_020838"
FT   VAR_SEQ         237..490
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_020839"
FT   VAR_SEQ         241
FT                   /note="E -> EAQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12975309"
FT                   /id="VSP_020840"
FT   VAR_SEQ         242..290
FT                   /note="VCPLPPMVSHGDFVCHPRPCERYNHGTVVEFYCDPGYSLTSDYKYITCQ ->
FT                   GGRPEHLFPVLYFPHIRLAAAVLYFCPVLKSSPTPAPTCSSTSTTTSLF (in
FT                   isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_020841"
FT   VAR_SEQ         291..490
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_020842"
FT   VAR_SEQ         478..490
FT                   /note="DIADEIPLMEEDP -> HHAHWVLFLRN (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12975309"
FT                   /id="VSP_020843"
SQ   SEQUENCE   490 AA;  53778 MW;  15392C2774BEFF22 CRC64;
     MYHGMNPSNG DGFLEQQQQQ QQPQSPQRLL AVILWFQLAL CFGPAQLTGG FDDLQVCADP
     GIPENGFRTP SGGVFFEGSV ARFHCQDGFK LKGATKRLCL KHFNGTLGWI PSDNSICVQE
     DCRIPQIEDA EIHNKTYRHG EKLIITCHEG FKIRYPDLHN MVSLCRDDGT WNNLPICQGC
     LRPLASSNGY VNISELQTSF PVGTVISYRC FPGFKLDGSA YLECLQNLIW SSSPPRCLAL
     EVCPLPPMVS HGDFVCHPRP CERYNHGTVV EFYCDPGYSL TSDYKYITCQ YGEWFPSYQV
     YCIKSEQTWP STHETLLTTW KIVAFTATSV LLVLLLVILA RMFQTKFKAH FPPRGPPRSS
     SSDPDFVVVD GVPVMLPSYD EAVSGGLSAL GPGYMASVGQ GCPLPVDDQS PPAYPGSGDT
     DTGPGESETC DSVSGSSELL QSLYSPPRCQ ESTHPASDNP DIIASTAEEV ASTSPGIDIA
     DEIPLMEEDP
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024